Melioidosis — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — IV meropenem 1 g 8-hourly for ≥14 days
Melioidosis (caused by B. pseudomallei, endemic in tropical northern Australia) requires a two-phase treatment approach. The intensive phase uses IV meropenem (or ceftazidime) for a minimum of 10–14 days (often extended to 4–6 weeks for severe disease). This is followed by prolonged eradication therapy with oral TMP-SMX (± doxycycline) for at least 3–6 months to prevent relapse. Risk factors include diabetes, heavy alcohol use, CKD, and immunosuppression.
Reference: eTG – 2025 – Antibiotic Guidelines; Darwin Melioidosis Guidelines – 2024